South and Central America Artificial Tears Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Type (Cellulose Derived Tears, Glycerin Derived Tears, Oil-based Emulsion Tears, Polythylene Glycol Based Tears, Propylene Glycol Based Tears, and Sodium Hyaluronate Based Artificial Tears); Delivery Mode (Eye Drops, and Ointments); Application (Dry Eyes Treatment, and Contact Lenses Moisture)


No. of Pages: 120    |    Report Code: TIPRE00023495    |    Category: Life Sciences

South and Central America Artificial Tears Market
Buy Now

Market Introduction

Artificial tears are lubricant eye drops used for treating the irritation and dryness associated with the deficiency in tear production in dry eyes or keratoconjunctivitis sicca. These are also used for moistening contact lenses and during eye check-ups and examinations. The rapidly growing aging population is primarily contributing to the growth of the artificial tears market. Aging makes people more susceptible to eye conditions such as dry eye, resulting in high demand for artificial tears. Also, increasing number of eye surgeries and post eye surgery management is further boosting the growth of the artificial tears market.

Thus, a growing older population is expected to create a significant demand for artificial tears in the coming years, which is further anticipated to drive the artificial tears market.

The COVID-19 pandemic presented numerous impacts on health systems, social life, and human behavior worldwide. It remains a challenge for local communities. In Brazil, a decrease in the number of treated patients was observed in the Artificial Tears department despite efforts to keep the treatment routine as normal as possible. Nevertheless, a higher decrease in the total number of sessions was detected, indicating a smaller number of fractions/patients overall. According to International Labour Organization, one such survey for Brazil (XP Investments) estimates that 35% of workers are working from home. According to International Labour Organization, With the COVID-19 pandemic, the percentage of workers teleworking has risen tremendously, as companies have taken steps to facilitate the practice in an effort to keep their operations ongoing. A March 25th survey of 250 large firms in Argentina found, for example, that 93% had adopted teleworking as a policy in response to the COVID-19 pandemic. This triggers incidence of dry eye syndrome (DES). These factors had a potential impact on the South and Central America artificial tears market.

 


Get more information on this report

South and Central America Artificial Tears Strategic Insights

Strategic insights for the South and Central America Artificial Tears provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/south-and-central-america-artificial-tears-market-strategic-framework.webp
Get more information on this report

South and Central America Artificial Tears Report Scope

Report Attribute Details
Market size in 2021 US$ 94.0 Million
Market Size by 2028 US$ 130.3 Million
Global CAGR (2021 - 2028) 4.8%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Type
  • Cellulose Derived Tears
  • Glycerin Derived Tears
  • Oil-based Emulsion Tears
  • Polythylene Glycol Based Tears
  • Propylene Glycol Based Tears
  • Sodium Hyaluronate Based Artificial Tears
By Delivery Mode
  • Eye Drops
  • Ointments
By Application
  • Dry Eyes Treatment
  • Contact Lenses Moisture
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Johnson and Johnson Services, Inc.
  • Alcon Inc.
  • OASIS Medical
  • AbbVie Inc.
  • Bayer AG
  • Prestige Consumer Healthcare Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Bausch Health Companies Inc.
  • Get more information on this report

    South and Central America Artificial Tears Regional Insights

    The geographic scope of the South and Central America Artificial Tears refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/south-and-central-america-artificial-tears-market-geography.webp
    Get more information on this report


    Market Overview and Dynamics

    The Artificial tears market in South and Central America is expected to grow from US$ 94.0 million in 2021 to US$ 130.3 million by 2028; it is estimated to grow at a CAGR of 4.8% from 2021 to 2028. The industry is witnessing a considerable number of business activities that are generating a very lucrative growth opportunity for the market. The players in the industry are focusing on brand establishments, as well as consolidation of supply chain distribution channels with an aim to leverage their presence in the global market. For instance, in March 2020, Grafton Optical launched I-DROP MGD Viscoadaptive Tears that provide the relief for severe chronic evaporative dry eye. I-DROP MGD is preservative-free, artificial tear that helps relieve symptoms associated with evaporative dry eye, for patients suffering from Meibomian Gland Dysfunction. It is the most advanced eye drop for hydrating and lubricating the cornea. In addition, the companies are working proactively to launch advanced products in the market. For instance, in March 2020, Alcon, the global leader in eye care introduced SYSTANE HYDRATION Preservative-Free (PF) Lubricant Eye Drops for dry eye. It is used to relieve dryness of the eye and as a protectant against further irritation. Further, in October 2019, Allergan launched a new product line called Refresh Relieva lubricant eye. The launch of the novel product has helped the company retain its position in the eye drop industry. Such strategic events are likely to offer lucrative growth opportunity for the artificial tears market during the forecast period.

     

    Key Market Segments

    In terms of type, the glycerin derived tears segment accounted for the largest share of the South and Central America artificial tears market in 2020. In terms of delivery mode, the eye drops segment accounted for the largest share of the South and Central America artificial tears market in 2020. In terms of application, the dry eyes treatment segment held a larger market share of the artificial tears market in 2020.

     

    Major Sources and Companies Listed

    A few major primary and secondary sources referred to for preparing this report on the Artificial tears market in South and Central America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Johnson and Johnson Services, Inc.

    ,

    Alcon Inc.

    ,

    OASIS Medical

    ,

    AbbVie Inc.

    ,

    Bayer AG

    ,

    Prestige Consumer Healthcare Inc.

    ,

    Santen Pharmaceutical Co., Ltd., and Bausch Health Companies Inc.

     

    Reasons to buy report

    • To understand the South and Central America Artificial tears market landscape and identify market segments that are most likely to guarantee a strong return
    • Stay ahead of the race by comprehending the ever-changing competitive landscape for South and Central America Artificial tears market
    • Efficiently plan M&A and partnership deals in South and Central America Artificial tears market by identifying market segments with the most promising probable sales
    • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form South and Central America Artificial tears market
    • Obtain market revenue forecast for market by various segments from 2021-2028 in South and Central America region.

     

    SOUTH AND CENTRAL AMERICA ARTIFICIAL TEARS MARKET SEGMENTATION

    By Type

    • Glycerin Derived Tears
    • Cellulose Derived Tears
    • Oil-based Emulsion Tears
    • Polythylene Glycol Based Tears
    • Sodium Hyaluronate Based Artificial Tears
    • Propylene Glycol Based Tears

     

    By Delivery Mode

    • Eye Drops
    • Ointments

     

     

    By Application

    • Dry Eyes Treatment
    • Contact Lenses Moisture

     

    By Country

    • South and Central America
      • Brazil
      • Argentina
      • Rest of South and Central America

     

    Companies Mentioned

    1. Johnson and Johnson Services, Inc.
    2. Alcon Inc.
    3. OASIS Medical
    4. AbbVie Inc.
    5. Bayer AG
    6. Prestige Consumer Healthcare Inc.
    7. Santen Pharmaceutical Co., Ltd.
    8. Bausch Health Companies Inc.

     

     

    The List of Companies - South and Central America Artificial Tears Market

    1. Johnson and Johnson Services, Inc.
    2. Alcon Inc.
    3. OASIS Medical
    4. AbbVie Inc.
    5. Bayer AG
    6. Prestige Consumer Healthcare Inc.
    7. Santen Pharmaceutical Co., Ltd.
    8. Bausch Health Companies Inc.

     

    Frequently Asked Questions
    How big is the South and Central America Artificial Tears Market?

    The South and Central America Artificial Tears Market is valued at US$ 94.0 Million in 2021, it is projected to reach US$ 130.3 Million by 2028.

    What is the CAGR for South and Central America Artificial Tears Market by (2021 - 2028)?

    As per our report South and Central America Artificial Tears Market, the market size is valued at US$ 94.0 Million in 2021, projecting it to reach US$ 130.3 Million by 2028. This translates to a CAGR of approximately 4.8% during the forecast period.

    What segments are covered in this report?

    The South and Central America Artificial Tears Market report typically cover these key segments-

    • Type (Cellulose Derived Tears, Glycerin Derived Tears, Oil-based Emulsion Tears, Polythylene Glycol Based Tears, Propylene Glycol Based Tears, Sodium Hyaluronate Based Artificial Tears)
    • Delivery Mode (Eye Drops, Ointments)
    • Application (Dry Eyes Treatment, Contact Lenses Moisture)

    What is the historic period, base year, and forecast period taken for South and Central America Artificial Tears Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Artificial Tears Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in South and Central America Artificial Tears Market?

    The South and Central America Artificial Tears Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Johnson and Johnson Services, Inc.
  • Alcon Inc.
  • OASIS Medical
  • AbbVie Inc.
  • Bayer AG
  • Prestige Consumer Healthcare Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Bausch Health Companies Inc.
  • Who should buy this report?

    The South and Central America Artificial Tears Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South and Central America Artificial Tears Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now